A shocking trend is emerging in India where young adults are being diagnosed with advanced fatty liver despite normal enzyme levels. Experts warn that traditional blood tests may fail to detect this silent killer.
- Fatty liver often presents no symptoms in over 80% of patients.
- Normal liver enzyme levels (ALT/AST) do not rule out the presence of liver fat or fibrosis.
- FibroScan is essential for detecting liver stiffness and irreversible scarring.
- Lean individuals are also susceptible to metabolically dysfunctional-associated fatty liver disease.
The case of Aman, a 27-year-old resident of Noida, serves as a stark warning for the modern generation. What began as simple digestive issues—bloating and irregular bowel movements—eventually revealed a severe medical condition: Grade 2-3 fatty liver with a liver fibrosis score of 6. Despite initial treatments that seemed to stabilize his liver enzymes, the underlying damage continued to progress, highlighting the deceptive nature of the disease.
Medical professionals explain that a Grade 2-3 diagnosis indicates significant fat deposits, while a fibrosis score of 6 suggests that the liver has begun to scar and stiffen. This scarring, known as fibrosis, is a critical stage that can lead to permanent, irreversible damage if not managed aggressively through medication and drastic lifestyle changes.
Why This Matters
BozokMedia analysis shows that there is a dangerous gap between perceived health and clinical reality in urban India. The reliance on basic Liver Function Tests (LFTs) is creating a false sense of security. When 74% of people with ultrasound-confirmed fatty liver show normal enzymes, the medical community must pivot toward more advanced screening for at-risk populations, regardless of their weight or age.
"Fatty liver is largely a silent disease; a normal Liver Function Test does not necessarily rule out the condition, as ALT and AST can remain normal even while fat accumulates."
According to the Apollo Hospitals Health of the Nation Report 2026, the prevalence of non-communicable diseases (NCDs) among Indian youth is alarming. Among 100,000 people under 30, 59% were overweight or obese, and over half suffered from abnormal cholesterol levels. This systemic health decline is creating a fertile ground for early-onset liver diseases.
To combat this, patients like Aman have adopted rigorous regimens. His recovery involves a strict protein-controlled diet (1g per kg of body weight), the consumption of black coffee and green tea, and a complete avoidance of sugary, oily, and processed foods. He also utilizes specialized medications like Bilypsa and Vitamin E under the supervision of the Institute of Liver and Biliary Sciences (ILBS).
Dr. M Irtaza emphasizes that the distinction between 'fatty liver' and 'fibrosis' is vital. While fat can often be reversed, fibrosis is a precursor to cirrhosis. He notes that 20-30% of patients are 'lean,' proving that a thin physique does not guarantee a healthy metabolism.
| Test Type | What it Measures | Limitation |
|---|---|---|
| Liver Function Test (LFT) | Enzymes (ALT, AST), Bilirubin | Can be normal even in advanced fatty liver. |
| Ultrasound | Fat accumulation/Liver size | Cannot determine the extent of scarring (fibrosis). |
| FibroScan | Liver stiffness/Elasticity | More specialized and expensive than ultrasound. |
Frequently Asked Questions
Q1: Can I have fatty liver if I am thin?
Yes, 20-30% of patients are lean. This is often due to metabolically dysfunctional-associated fatty liver disease, where internal metabolism is abnormal despite a low BMI.
Q2: What is the difference between Grade 3 fatty liver and Fibrosis?
Grade 3 refers to the amount of fat deposited in the liver, whereas fibrosis refers to the actual scarring and stiffening of the tissue. You can have high-grade fat without fibrosis, or low-grade fat with significant fibrosis.
